A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry**This work was presented at the American Association of Pharmaceutical Scientists Annual meeting, Salt Lake City, USA, Oct. 26, 2003.
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 95 (8) , 1783-1799
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to manXenobiotica, 2000
- Disposition of the Selective α1A-Adrenoceptor Antagonist Tamsulosin in Humans: Comparison with Data from Interspecies ScalingJournal of Pharmaceutical Sciences, 1997
- Clinical Pharmacokinetics of InterferonsClinical Pharmacokinetics, 1990
- Prediction of the pharmacokinetics of cefodizime and cefotetan in humans from pharmacokinetic parameters in animals.Journal of Pharmacobio-Dynamics, 1990
- Comparative pharmacokinetics and interspecies scaling of 3'-azido-3'-deoxythymidine(AZT) in several mammalian species.Journal of Pharmacobio-Dynamics, 1990
- Pharmacokinetic and pharmacodynamic modelling of metoprolol in rabbits with liver failureEuropean Journal of Drug Metabolism and Pharmacokinetics, 1989
- Pharmacokinetics of Nilvadipine in Healthy VolunteersThe Journal of Clinical Pharmacology, 1987
- Physiological pharmacokinetic modeling ofcis-dichlorodiammineplatinum(II) (DDP) in several speciesJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animalsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982